Literature DB >> 9185526

Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland.

M J Abramowicz1, L Duprez, J Parma, G Vassart, C Heinrichs.   

Abstract

Thyroid gland agenesis is the most common cause of congenital hypothyroidism and is usually sporadic. We investigated a brother and sister from consanguineous parents, ascertained through systematic newborn screening, and initially diagnosed with thyroid agenesis. Careful cervical ultrasonography in both patients revealed a very hypoplastic thyroid gland. By direct sequencing of the thyrotropin receptor gene, we identified the substitution of threonine in place of a highly conserved alanine at position 553, in the fourth predicted transmembrane domain. The mutation was found homozygous in the affected siblings, and heterozygous in both parents and two unaffected siblings. Functional analysis in transfected COS-7 cells showed that it resulted in extremely low expression at the cell surface as compared with the wild-type receptor, in spite of an apparently normal intracellular synthesis. The small amount of mutated receptor expressed at the surface of transfected cells bound thyrotropin with normal affinity and responded in terms of cAMP production, but the in vivo significance of these data from overexpressed receptor in transfected cells is unclear. Of note, blood thyroglobulin was unexpectedly elevated in the patients at the time of diagnosis, a finding that might prove useful in refining etiologies of congenital hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185526      PMCID: PMC508154          DOI: 10.1172/JCI119497

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Engineering human glycoprotein hormone superactive analogues.

Authors:  M W Szkudlinski; N G Teh; M Grossmann; J E Tropea; B D Weintraub
Journal:  Nat Biotechnol       Date:  1996-10       Impact factor: 54.908

2.  Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor.

Authors:  Y Nagayama; K D Kaufman; P Seto; B Rapoport
Journal:  Biochem Biophys Res Commun       Date:  1989-12-29       Impact factor: 3.575

3.  Congenital hypothyroidism with impaired thyroid response to thyrotropin.

Authors:  J B Stanbury; P Rocmans; U K Buhler; Y Ochi
Journal:  N Engl J Med       Date:  1968-11-21       Impact factor: 91.245

4.  Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies.

Authors:  F Libert; A Lefort; C Gerard; M Parmentier; J Perret; M Ludgate; J E Dumont; G Vassart
Journal:  Biochem Biophys Res Commun       Date:  1989-12-29       Impact factor: 3.575

5.  Molecular cloning of the thyrotropin receptor.

Authors:  M Parmentier; F Libert; C Maenhaut; A Lefort; C Gérard; J Perret; J Van Sande; J E Dumont; G Vassart
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

6.  Evaluation and characterization of the hyt/hyt hypothyroid mouse. II. Abnormalities of TSH and the thyroid gland.

Authors:  S A Stein; D R Shanklin; L Krulich; M G Roth; C M Chubb; P M Adams
Journal:  Neuroendocrinology       Date:  1989-05       Impact factor: 4.914

7.  Plasma thyroglobulin measurements help determine the type of thyroid defect in congenital hypothyroidism.

Authors:  P Czernichow; M Schlumberger; R Pomarede; P Fragu
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

8.  High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment.

Authors:  M A Lopata; D W Cleveland; B Sollner-Webb
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

9.  Inherited primary hypothyroidism in mice.

Authors:  W J Beamer; E M Eicher; L J Maltais; J L Southard
Journal:  Science       Date:  1981-04-03       Impact factor: 47.728

10.  Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

View more
  32 in total

Review 1.  Thyrotropin receptor mutations in thyroid diseases.

Authors:  P M Yen
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Ultrasound of the thyroid gland in the newborn: normative data.

Authors:  R J Perry; A S Hollman; A M Wood; M D C Donaldson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

Review 3.  Parapharyngeal ectopic thyroid: the possible persistence of the lateral thyroid anlage. Clinical case report.

Authors:  A Soscia; G Guerra; M-P Cinelli; D Testa; V Galli; V Macchi; R De Caro
Journal:  Surg Radiol Anat       Date:  2004-05-08       Impact factor: 1.246

Review 4.  The molecular causes of thyroid dysgenesis: a systematic review.

Authors:  I C Nettore; V Cacace; C De Fusco; A Colao; P E Macchia
Journal:  J Endocrinol Invest       Date:  2013-05-22       Impact factor: 4.256

Review 5.  Resistance to thyrotropin.

Authors:  Helmut Grasberger; Samuel Refetoff
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2017-03-30       Impact factor: 4.690

6.  TSH receptor function is required for normal thyroid differentiation in zebrafish.

Authors:  Robert Opitz; Emilie Maquet; Maxime Zoenen; Rajesh Dadhich; Sabine Costagliola
Journal:  Mol Endocrinol       Date:  2011-07-07

7.  Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site.

Authors:  J Pohlenz; I M Rosenthal; R E Weiss; S M Jhiang; C Burant; S Refetoff
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 8.  Regenerative therapy for hypothyroidism: Mechanisms and possibilities.

Authors:  Anthony N Hollenberg; Jinyoung Choi; Maria Serra; Darrell N Kotton
Journal:  Mol Cell Endocrinol       Date:  2016-11-19       Impact factor: 4.102

Review 9.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 10.  Resistance to thyrotropin.

Authors:  S Refetoff
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.